Head-To-Head Contrast: Teladoc Health (TDOC) versus Its Peers

Teladoc Health (NYSE:TDOC) is one of 94 public companies in the “Medical Services” industry, but how does it weigh in compared to its competitors? We will compare Teladoc Health to similar businesses based on the strength of its earnings, risk, analyst recommendations, dividends, institutional ownership, profitability and valuation.

Profitability

This table compares Teladoc Health and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-8.16%	-10.13%	-4.43%
Teladoc Health Competitors	-745.62%	-27.20%	-12.22%

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Teladoc Health and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	0	12	7	0	2.37
Teladoc Health Competitors	426	2278	4868	157	2.62

Teladoc Health presently has a consensus target price of $9.76, suggesting a potential upside of 40.69%. As a group, “Medical Services” companies have a potential upside of 447.08%. Given Teladoc Health’s competitors stronger consensus rating and higher possible upside, analysts clearly believe Teladoc Health has less favorable growth aspects than its competitors.

Earnings & Valuation

This table compares Teladoc Health and its competitors gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Teladoc Health	$2.57 billion	-$1.00 billion	-5.83
Teladoc Health Competitors	$9.34 billion	$238.11 million	37.89

Teladoc Health’s competitors have higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Risk and Volatility

Teladoc Health has a beta of 1.76, suggesting that its stock price is 76% more volatile than the S&P 500. Comparatively, Teladoc Health’s competitors have a beta of 1.64, suggesting that their average stock price is 64% more volatile than the S&P 500.

Insider & Institutional Ownership

76.8% of Teladoc Health shares are held by institutional investors. Comparatively, 58.1% of shares of all “Medical Services” companies are held by institutional investors. 0.6% of Teladoc Health shares are held by company insiders. Comparatively, 13.1% of shares of all “Medical Services” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Teladoc Health competitors beat Teladoc Health on 8 of the 13 factors compared.

Teladoc Health Company Profile

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.